Impact of timing of adjuvant chemotherapy initiation on survival for elderly patients with stage III colon cancer in Norway - a register-based cohort study.

BMC Cancer · 2025 · PMC12522661 · PMID 41088091

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

borderline significantno p-value reported

For high risk patients, ACT during weeks 1–6 and 9–10 was significantly associated with decreased hazard of death, with weeks 7–8 being borderline significant: (1–6 weeks: HR 0.77, 95% CI: 0.61–0.98; 7–8 weeks: HR 0.82, 95% CI: 0.65–1.03; 9–10 weeks: HR 0.65, 95% CI: 0.46–0.92).

also in 11,409 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.